References

gnck

Колопроктология

Koloproktologia

2073-75562686-7303

Russian Association of Coloproctology

10.33878/2073-7556-2017-0-3-63-70

gnck-323

Research Article

ОБЗОР ЛИТЕРАТУРЫ

REVIEW

ПРОТИВОРЕЦИДИВНАЯ ТЕРАПИЯ БОЛЕЗНИ КРОНА В ПОСЛЕОПЕРАЦИОННОМ ПЕРИОДЕ (обзор литературы)

POSTOPERATIVE PREVENTIVE TREATMENT OF CROHN'S DISEASE (review)

Халиф

И. Л.

Khalif

I. L.

noemail@neicon.ru

Варданян

А. В.

Vardanyan

A. V.

noemail@neicon.ru

Шапина

М. В.

Shapina

M. V.

noemail@neicon.ru

Полетова

А. В.

Poletova

A. V.

poletova35@gmail.com

ФГБУ «ГНЦК им. А.Н.Рыжих» Минздрава РоссииРоссияState Scientific Centre of ColoproctologyRussian Federation

2017

30092017

036370

2017

Халиф И.Л., Варданян А.В., Шапина М.В., Полетова А.В.

Khalif I.L., Vardanyan A.V., Shapina M.V., Poletova A.V.

Данная работа распространяется под лицензией Creative Commons Attribution 4.0.

This work is licensed under a Creative Commons Attribution 4.0 License.

https://www.ruproctology.com/jour/article/view/323

болезнь Кронарецидивтерапия

Crohn's diseaserecurrencetreatment

References1

Воробьев, Г.И. Неспецифические воспалительные заболевания кишечника / Г.И.Воробьев, И.Л.Халиф // М.: Миклош, 2008. - с. 248-251.

Головенко, А.О. Профилактика послеоперационных рецидивов болезни Крона. / A.О.Головенко, И.Л.Халиф, О.В.Головенко и соавт. // Колопроктология. - 2012. - 4 (42). - с. 40-48.

Голышева, С.В. Качество жизни больных неспецифическим язвенным колитом и болезнью Крона до и после операции. / С.В.Голышева // Автореферат дис.. канд. мед. наук. - Москва: Первый МГМУ им. Сеченова, 2007. - с. 24.

Репетий, Н.Г. Язвенный колит и болезнь Крона: о выборе решения к переходу от консервативного лечения к хирургическому / Н.Г.Репетий, B.Б.Александров, О.Ю.Рахимова // Медицинский Вестник МВД. - 2010. - 4 (47). - с. 12-15.

Agrez, M.V. et al. Surgical history of Crohn’s disease in a well-defined population. / M.V.Agrez. // Mayo Clin Proc. - 1982. - 57 (12). - р. 747-752.

Aguas, M. Adalimumab in prevention of postoperative recurrence of Crohn’s disease in high-risk patients. / M.Aguas, G.Bastida, E.Cerrillo, et al. // World J. Gastroenterol. - 2012. - 18 (32). - р. 43914398.

Araki, T. The impact of postoperative infliximab maintenance therapy on preventing the surgical recurrence of Crohn’s disease: a single-center paired case-control study. / T.Araki, K.Uchida, Y.Okita, et al. // Surg. Today. - 2014. - 44 (2). - р. 291-296.

Ardizzone, S. Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn’s disease. / S.Ardizzone, G.Maconi, G.M.Sampietro et al. // Gastroenterology. - 2004. -127. - р. 730-740.

Armuzzi, A. Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn’s disease: an open-label pilot study. / M.Regueiro, K.E.Kip, L.Baidoo et al. // J. Crohns Colitis. - 2013. -7 (12). - р. 623-629.

Bernell, O. Risk factors for surgery and postoperative recurrence in Crohn’s disease. / O.Bernell, A.Lapidus, G.Hellers. // Ann. Surg. -2000. - 231. - р. 38-45.

Bernell, O. Risk factors for surgery and recurrence in 907 patients with primary ileocaecalCrohn’s disease. / O.Bernell, A.Lapidus, G.Hellers // Br. J. Surg. - 2000. - 87 (12). - р. 1697-701.

D’Haens, GR. Early lesions of recurrent Crohn’s disease caused by infusion of intestinal contents in excluded ileum. / G.R.D’Haens, K.Geboes, M.Peeters et al. // Gastroenterology. - 1998. - 114. - p. 262-267.

De Cruz, P. Crohn’s disease management after intestinal resection: a randomised trial. / P.De Cruz, M.A.Kamm, A.L.Hamilton et al. // Lancet. - 2015. -385 (9976). - Р. 1406-1417.

Doherty, G. Interventions for prevention of postoperative recurrence of Crohn’s disease. / G.Doherty, G.Bennett, S.Patil et al. // Cochrane Database Syst Rev. - 2009: - 10.1002/14651858.CD006873.pub2.

Ewe, K. Postoperative recurrence of Crohn’s disease in relation to radicality of operation and sulfasalazine prophylaxis: a multicenter trial. / K.Ewe, C.Herfarth, H.Malchow et al. // Digestion. - 1989. - 42. - p. 224-232.

Ford, A.C. 5-aminosalicylates prevent relapse of Crohn’s disease after surgically induced remission: systematic review and meta-analysis. / A.C.Ford, K.J.Khan, N.J.Talley et al. // Am. J. Gastroenterol. - 2011. - 106 (3). - p. 413-420.

Greenstein, A.J. Perforating and nonperforating indications for repeated operations in Crohn’s disease: evidence for two clinical forms. / A.J.Greenstein et al. // Gut. - 1988. - 29 (5). - p. 588-592.

Hanauer, S.B. Postoperative maintenance of Crohn’s disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. / S.B.Hanauer, B.I.Korelitz, P.Rutgeerts et al. // Gastroenterology. -2004. - 127. - p. 723-729.

Harvey, R.F. A simple index of Crohn’s-disease activity. / R.F.Harvey, J.M.Bradshaw. // Lancet. -1980. - 1 (8167). - p. 514.

Hashash, J.G. A Practical Approach to Preventing Postoperative Recurrence in Crohn’s Disease. /J.G.Hashash, M.Regueiro. // Curr. Gastroenterol. Rep. - 2016. - May. - 18 (5). - p. 25.

Hashash, J.G. The evolving management of postoperative Crohn’s disease. / J.G.Hashash, M.D.Regueiro // Expert Rev. Gastroenterol. Hepatol. - 2012. - 6 (5). - p. 637-48.

Hellers, G. Crohn’s disease in Stockholm county 1955-1974. A study of epidemiology, results of surgical treatment and long-term prognosis. / G.Hellers // Acta. Chir. Scand. Int. J. Colorectal Disease. - 2007. -22 (9). - p. 1043-1049.

Herfarth, H.H. Inflamm Bowel. / H.H.Herfarth, A.J.Katz, S.B.Hanauer et al.// Dis. - 2013. - 19 (5). -p. 1073-1079.

Hofer, B. The impact of clinical types of disease manifestation on the risk of early postoperative recurrence in Crohn’s disease. / B.Hofer et al. // Hepatogastroenterology. - 2001. - 48 (37). - p. 152155.

Jason, M. Swoger and Miguel Regueiro Preventive therapy in postoperative Crohn’sdisease. / M. Jason. // Current Opinion in Gastroenterology. - 2010. - 26. - p. 337-343.

Kane, S.V. Tobacco use is associated with accelerated clinical recurrence of Crohn’s disease after surgically induced remission. / S.V.Kane, M.Flicker, F.Katz-Nelson // J. Clin. Gastroenterol. - 2005. -39 (1). - p. 32-35.

Latella, G. Results of the 4th scientific workshop of the ECCO (I): pathophysiology of intestinal fibrosis in IBD. / G.Latella, G.Rogler, G.Bamias et al. // J. Crohns Colitis. - 2014. - pii: S1873-9946 (14) 00120-S1873-9946(14) 00122.

McLeod, R.S. Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn’s disease. / R.S.McLeod, B.G.Wolff, A.H.Steinhart et al. // Gastroenterology. - 1995. - 109. - p. 404-413.

Michelassi, F. Primary and recurrent Crohn’s disease. Experience with 1379 patients. / F.Michelassi, T.Balestracci, R.Chappel et al. // Ann. Surg. - 1991. -214. - p. 230-238.

Modigliani, R. Clinical, biological and endoscopy picture of attacks of Crohn’s disease. Evolution on prednisolone. / R.Modigliani, J.Mary, J.Simon // Gastroenterology. - 1990. - 98. - p. 811-818.

Ng, S.C. Management of postoperative Crohn’s disease. / S.C.Ng, M.A.Kamm // Am. J. Gastroenterol. - 2008. - 103 (4). - p. 1029-1035.

Otley, A. Budesonide for induction of remission in Crohn’s disease. / A.Otley, AH.Steinhart // Cochrane Database Syst. Rev. - 2005. - CD000296. - Review.

Papamichael, K. Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn’s disease: a prospective, two-year, single center, pilot study. / K.Papamichael, E.Archavlis, C.Lariou et al. // J. Crohns Colitis. - 2012. - 6 (9). - p. 924-931.

Peyrin-Biroulet, L. Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn’s disease: a meta-analysis. / L.Peyrin-Biroulet, P.Deltenre, S.Ardizzone et al. // Am. J. Gastroenterol. - 2009. - 104. - p. 2089-2096.

Peyrin-Biroulet, L. Surgery in a population-based cohort of Crohn’s disease from Olmsted County, Minnesota (1970-2004). / L.Peyrin-Biroulet, W.S.Harmsen, W.J.Tremaine et al. // Am. J. Gastroenterol. - 2012. - 107. - p. 1693-1701.

Reese, G.E. The effect of smoking after surgery for Crohn’s disease: a meta-analysis of observational studies. / G.E.Reese, T.Nanidis, C.Borysiewicz et al. // Int. J. Color Dis. - 2008. - 23 (12). - p. 1213-1221.

Regueiro, M. Infliximab prevents Crohn’s disease recurrence after ileal resection. / M.Regueiro, W.Schraut, L.Baidoo et al. // Gastroenterology. -2009. - 136 (2). - p. 441-450.

Regueiro, M. Infliximab Reduces Endoscopic, but not Clinical, Recurrence of Crohn’s Disease Following Ileocolonic Resection. / M.Regueiro, B.G.Feagan, B.Zou et al. // Gastroenterology. - 2016. - 150 (7).

Regueiro, M. Postoperative infliximab is not associated with an increase in adverse events in Crohn’s disease. / M.Regueiro, S.El-Hachem, K.E.Kip et al. // Dig. Dis. Sci. - 2011. - 56 (12). - p. 3610-3615.

Regueiro, M. Postoperative therapy with infliximab prevents long-term Crohn’s disease recurrence. / M.Regueiro, K.E.Kip, L.Baidoo et al. // Clin. Gastroenterol. Hepatol. - 2014. - 12. - p. 1494-502.

Rutgeerts, P. Controlled trial of metronidazole treatment for prevention of Crohn’s recurrence after ileal resection. / P.Rutgeerts, M.Hiele, K.Geboes et al. // Gastroenterology. - 1995. - 108. - Р. 1617-1621.

Rutgeerts, P. Ornidazole for prophylaxis of postoperative Crohn’s disease recurrence: a randomized, double-blind, placebo-controlled trial. / P.Rutgeerts et al. // Gastroenterology. - 2005. -128 (4). - p. 856-861.

Sakuraba, A. The use of infliximab in the prevention of postsurgical recurrence in polysurgeryCrohn’s disease patients: a pilot open-labeled prospective study. / A.Sakuraba, T.Sato, H.Matsukawa et al. // Int. J. Colorectal Dis. - 2012. - 27 (7) - p. 947-952.

Savarino, E. Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn’s disease: a randomized controlled trial. / E.Savarino, G.Bodini, P.Dulbecco et al. // Am. J. Gastroenterol. - 2013. - 108 (11). - p. 1731-1742.

Savarino, E. Prevention of postoperative recurrence of Crohn’s disease by Adalimumab: a case series. / E.Savarino, P.Dulbecco, G.Bodini et al. // Eur. J. Gastroenterol. Hepatol. - 2012. - 24 (4). -p. 468-70.

Simillis, C. A meta-analysis comparing incidence of recurrence and indication for reoperation after surgery for perforating versus nonperforating Crohn’s disease. / C.Simillis, T.Yamamoto, G.E.Reese et al. // Am. J. Gastroenterol. - 2008. - 103 (1). - p. 196-205.

Sorrentino, D. Infliximab with low-dose methotrexate for prevention of postsurgical recurrence of ileocolonic Crohn disease. / D.Sorrentino, G.Terrosu, C.Avellini et al. // Arch. Intern. Med. -2007. - 167 (16). - p. 1804-1807.

Sorrentino, D. Low-dose maintenance therapy with infliximab prevents postsurgical recurrence of Crohn’s disease. / D.Sorrentino, A.Paviotti, G.Terrosu et al. // Clin. Gastroenterol. Hepatol. - 2010. - 8 (7). -p. 591-599.

Sorrentino, D. Prevention of postoperative recurrence of Crohn’s disease by infliximab. / D.Sorrentino, G.Terrosu, C.Avellini et al. // Eur. J. Gastroenterol. Hepatol. - 2006. - 18 (4). - p. 457-459.

Sorrentino, D. State-of-the-art medical prevention of postoperative recurrence of Crohn’s disease. / D.Sorrentino. // Nat. Rev. Gastroenterol. Hepatol. -2013. - 10 (7). - p. 413-422.

Steinhart, A.H. Corticosteroids for maintaining remission of Crohn’s disease. / A.H.Steinhart, K.Ewe, A.M.Griffiths et al. // Cochrane Database Syst. Rev. - 2003. - CD000301.

Terdiman, J.P. Prevention of postoperative recurrence in Crohn’s disease. / J.P.Terdiman. // Clin. Gastroenterol. Hepatol. - 2008. - 6 (6). - p. 616620.

Yamamoto, T. Factors affecting recurrence after surgery for Crohn’sdisease. / T.Yamamoto. // World. J. Gastroenterol. - 2005. - 11 (26). - p. 3971-3979.

Yamamoto, T. Strategies for 25. the prevention of postoperative recurrence of Crohn’s disease. / T.Yamamoto, T.Watanabe. // Colorectal Disease. - 2013. - 15 (12). - p. 1471-1480.

The authors declare that there are no conflicts of interest present.